Eltek Reports Fourth Quarter and Full Year 2018 Financial Results

PETACH-TIKVA, Israel, April 17, 2019 /PRNewswire/ -- Eltek Ltd. (NASDAQ: ELTK), a global manufacturer and supplier of technologically advanced solutions in the field of printed circuit boards, announced today its financial results for the fourth quarter and full year ended December 31, 2018.

Mr. Eli Yaffe, Chief Executive Officer, commented:

"As recently announced, we established a new leadership team to implement our turnaround plan. We identified the products that were underpriced and declined such orders in order to increase profitability, which resulted in a reduced loss in 2018. During the fourth quarter this resulted in an initial reduction in sales volume, but we believe that this will improve our on-time delivery performance, increase customer satisfaction and build additional sales that will return us to profitability."

In March 2019, the Company issued at no charge to the holders of our ordinary shares subscription rights to purchase up to an aggregate of 3,380,920 shares, such that each shareholder received five subscription rights for every three ordinary shares owned on the record date, at a price of $1.464 per share. Our shareholders purchased 2,351,701 ordinary shares, for an aggregate of $3.4 million. The proceeds from the offering are strengthening our working capital and will be used to reduce our line of credit, as well as for general corporate purposes, including the possible investment in plant and equipment.

"I see significant potential for Eltek in the high-end PCB market with our skilled engineers and experienced management. I am optimistic that we will be able to capitalize on our strengths, return the Company to profitability and renew our position as a leading high-end PCB manufacturer," Mr. Yaffe concluded.

Highlights of the Full Year of 2018 compared to the Full Year of 2017

    --  Revenues for the full year of 2018 amounted to $33.9 million compared to
        revenues of $32.8 million in 2017.
    --  Gross profit was $2.6 million (7.7% of revenues) in 2018 compared to
        gross profit of $1.3 million (4.1% of revenues) in 2017.
    --  Operating loss was $2.1 million in 2018 compared to an operating loss of
        $3.4 million in 2017.
    --  Net loss was $2.6 million or $1.28 per fully diluted share in 2018,
        compared to a net loss of $3.8 million or $1.86 per fully diluted share
        in 2017.
    --  EBITDA was a negative $421,000 in 2018 compared to a negative $1.3
        million in 2017.
    --  Net cash used in operating activities amounted to $813,000 in 2018
        compared to $3.4 million used in operating activities in 2017.
    --  Cash and cash equivalents as of December 31, 2018 were $992,000,
        compared to $887,000 as of December 31, 2017.

Highlights of the Fourth Quarter of 2018 compared to the Fourth Quarter of 2017

    --  Revenues for the fourth quarter of 2018 were $7.8 million compared to
        revenues of $9.1 million in the fourth quarter of 2017.
    --  Gross profit was $603,000 (7.7% of revenues) in the fourth quarter of
        2018 compared to a loss of $740,000 (8.1% of revenues) in the fourth
        quarter of 2017.
    --  Operating loss was $416,000 in the fourth quarter of 2018 compared to an
        operating loss of $568,000 in the fourth quarter of 2017.
    --  Net loss was $631,000 or $0.31 per fully diluted share in the fourth
        quarter of 2018 compared to a net loss of $669,000 or $0.33 per fully
        diluted share in the fourth quarter of 2017.
    --  EBITDA was a negative $43,000 in the fourth quarter of 2018 compared to
        a negative $131,000 in the fourth quarter of 2017.
    --  Net cash provided from operating activities amounted to $136,000 in the
        fourth quarter of 2018 compared to $775,000 of cash used in operating
        activities in the fourth quarter of 2017.

Nasdaq Continued Listing Status

On October 2, 2018, we received notification from Nasdaq advising us that as of October 1, 2018, we did not maintain stockholders' equity of $2.5 million, nor did we meet the alternatives of market value of listed securities or net income from continuing operations, and therefore were not in compliance with the stockholders' equity listing rule. On December 7, 2018, we received a notice from Nasdaq advising that we had been granted an extension of time until March 31, 2019 to regain compliance with the stockholders' equity requirement. As a result of the receipt of approximately $2.5 million prior to March 31, 2019 from the recently completed rights offering, we regained compliance with Listing Rule 5550(b)(1) and our shares continue to be listed on the NASDAQ Capital Market. Nasdaq has advised us that it will continue to monitor our ongoing compliance with the shareholders' equity requirement and, if at the time of our next periodic report we do not evidence compliance, we may be subject to delisting.

Conference Call:

Today, Wednesday, April 17, 2019, at 8:30 a.m. Eastern Time, Eltek will conduct a conference call to discuss the results. The call will feature remarks by Mr. Eli Yaffe, Chief Executive Officer and Mr. Alon Mualem, Chief Financial Officer.

To participate, please call the following teleconference numbers. Please allow for additional time to connect prior to the call:

United States: 1-888-668-9141
Israel: 03-9180644
International: +972-3-9180644

At:
8:30 a.m. Eastern Time
5:30 a.m. Pacific Time
15:30 p.m. Israel Time

A replay of the call will be available through the Investor Info section on Eltek's corporate website at www.nisteceltek.com approximately 24 hours after the conference call is completed and will be archived for 30 days.

About Eltek

Eltek - "Innovation Across the Board", is a global manufacturer and supplier of technologically advanced solutions in the field of printed circuit boards (PCBs), and is the Israeli leader in this industry. PCBs are the core circuitry of most electronic devices. Eltek specializes in the manufacture and supply of complex and high quality PCBs, HDI, multilayered and flex-rigid boards for the high-end market. Eltek has ITAR, AS-9100 and NADCAP Electronics permits and its customers include top of the line companies in the defense, aerospace and medical industries in Israel, the United States, Europe and Asia.

Eltek was founded in 1970. The Company's headquarters, and R&D, production and marketing center is located in Israel. Eltek operates also through its subsidiaries in North America and Europe, and by agents and distributors in Europe, India, South Africa and South America.

For more information, visit Eltek's web site at www.nisteceltek.com.

Use of Non-GAAP Financial Information

The Company reports financial results in accordance with U.S. GAAP and herein provides some non-GAAP measures, including EBITDA. These non-GAAP measures are not in accordance with, nor are they a substitute for, GAAP measures. These non-GAAP measures are intended to supplement the Company's presentation of its financial results that are prepared in accordance with GAAP. The Company uses the non-GAAP measures presented to evaluate and manage the Company's operations internally. The Company is also providing this information to assist investors in performing additional financial analysis. Reconciliation between the company's results on a GAAP and non-GAAP basis is provided in a table below.

Safe Harbor for Forward Looking Statements:

This press release contains express or implied forward-looking statements within the Private Securities Litigation Reform Act of 1995 and other U.S Federal securities laws, that involve a number of risks and uncertainties including, but not limited, to statements regarding expected results in future quarters, risks in product and technology development and rapid technological change, product demand, the impact of competitive products and pricing, market acceptance, the sales cycle, changing economic conditions and other risk factors detailed in the Company's Annual Report on Form 20-F and in subsequent filings with the United States Securities and Exchange Commission. Except as otherwise required by law, Eltek is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking statements whether as a result of new information, future events or otherwise.


                                                             
         
              Eltek Ltd.


                                                       
       
         Consolidated Statements of Operations


                                                     
       
         (In thousands US$, except per share data)




                                                               Three months ended                                Twelve months ended



                                                                  December  31,                                     December  31,



                                                                             2018                           2017                           2018        2017






     
              Revenues                                                   7,827                          9,091                         33,939      32,754



     
              Costs of revenues                                        (7,224)                       (8,352)                      (31,342)   (31,427)






     
              Gross profit                                                 603                            740                          2,597       1,327





     Selling, general and administrative expenses                        (1,022)                       (1,305)                       (4,669)    (4,704)





     R&D expenses, net                                                         3                            (3)                                     (41)





     
              Operating loss                                             (416)                         (568)                       (2,072)    (3,418)





     Financial expenses, net                                               (211)                          (77)                         (475)      (298)



     Other income, net                                                         3                                                            3          16






     
              Loss before income tax                                     (623)                         (645)                       (2,544)    (3,700)





     Tax expenses                                                            (7)                          (24)                          (63)       (74)






     
              Net Loss                                                   (631)                         (669)                       (2,607)    (3,775)






     
              Earnings per share





     Basic and diluted net loss per ordinary share                        (0.31)                        (0.33)                        (1.28)     (1.86)






     Weighted average number of ordinary shares



     used to compute basic and diluted net loss per



     ordinary share (in thousands)                                         2,029                          2,029                          2,029       2,029








                                                                                
         
              Eltek Ltd.


                                                                            
         
         Consolidated Balance Sheets


                                                                              
         
            (In thousands US$)





                                                                                                                    As of December  31,



                                                                                                                                   2018      2017




              
                Assets





              
                Current assets



              Cash and cash equivalents                                                                                            992       887



              Receivables:   Trade, net of provision for doubtful accounts                                                       5,682     6,963



                                   Other                                                                                           868     1,527



              Inventories                                                                                                        3,611     3,871



              Prepaid expenses                                                                                                     292       254






              
                Total current assets                                                                                 11,445    13,502






              
                Long term assets



              Severance pay fund                                                                                                    53        57



              Long term prepaid expenses                                                                                            39




              
                Total long term assets                                                                                   92        57





              
                Fixed assets, less accumulated depreciation                                                           6,623     8,586






              
                Total assets                                                                                         18,160    22,145








              
                Liabilities and Shareholder's equity





              
                Current liabilities



              Short-term credit and current maturities of long-term debts                                                        6,606     7,063



              Short-term credit from related party                                                                               2,668     1,442



              Accounts payable: Trade                                                                                            4,108     5,451



                                          Other                                                                                  3,377     4,111






              
                Total current liabilities                                                                            16,759    18,067






              
                Long-term liabilities



              Long term debt, excluding current maturities                                                                         308       388



              Employee severance benefits                                                                                          211       231






              
                Total long-term liabilities                                                                             519       619






              
                Equity



              Ordinary shares, NIS 3.0  par value authorized 10,000,000                                                          1,985     1,985
    shares, issued and outstanding 2,028,552



              Additional paid-in capital                                                                                        17,270    17,270



              Cumulative foreign currency translation adjustments                                                                2,340     2,415



              Capital reserve                                                                                                      800       695



              Accumulated deficit                                                                                             (21,513) (18,906)



              
                Shareholders' equity                                                                                    882     3,459





              
                Total liabilities and shareholders' equity                                                           18,160    22,145


                                                                        
         
                Eltek Ltd.


                                                         
              
           Unaudited Non-GAAP EBITDA Reconciliations


                                                                    
         
                (In thousands US$)




                     Non-GAAP EBITDA Reconciliations Three months ended                                               Twelve months ended



                                                        December  31,                                                    December  31,



                                                                   2018                      2017                                              2018       2017







                     GAAP net Income (loss)                       (631)                    (669)                                          (2,607)   (3,775)


                                    Add back items:

    ---



        Financial expenses, net                                     211                        77                                               475        298



       Income tax expense                                            7                        23                                                63         74


        Depreciation and amortization                               370                       438                                             1,649      2,058



                     Adjusted EBITDA                               (43)                    (131)                                            (421)   (1,345)


                                                                    
       
                Eltek Ltd.


                                                       
              
         Consolidated Statement of  Cash flow


                                                                
         
              (In thousands US$)




                                                Three months ended                                           Twelve months ended



                                                   December  31,                                                December  31,



                                                              2018                   2017                                             2018       2017





      Cash flows from operating
       activities:





     Net Loss                                               (631)                 (669)                                         (2,607)   (3,775)




                   Adjustments to reconcile net
                    loss to net


       cash flows provided by
        operating activities:


      Depreciation and
       amortization                                            367                    438                                            1,649      1,722


      Capital lose on disposal of
       fixed assets, net                                       101                                                                    101       (13)


      Amortization of Intabgible
       assets                                                                                                                                  348


      Stock-based compensation                                  56                                                                     56


      Transaction with controlling
       shareholder                                              49                                                                     49


      Revaluation of long term
       loans                                                     6                     13                                               29         17


                                                               579                    451                                            1,884      2,075





      Decrease (increase) in trade
       receivables                                           1,264                  (975)                                             790      (597)


      Decrease (increase) in other
       receivables and prepaid
       expenses                                                155                  (447)                                             467    (1,249)


      Decrease (increase) in
       inventories                                             631                    541                                             (30)       471


      Increase (decrease) in trade
       payables                                            (1,518)                    69                                            (871)     (330)


      Increase (decrease) in other
       liabilities and accrued
       expenses                                              (309)                   187                                            (443)     (107)


      Increase (decrease) in
       employee severance
       benefits, net                                          (35)                    67                                              (3)        69


                                                               188                  (558)                                            (90)   (1,743)





                   Net cash provided by (used
                    in) operating activities                   136                  (775)                                           (813)   (3,444)





                   Cash flows from investing
                    activities:


      Purchase of fixed assets                               (425)                  (43)                                           (619)     (275)


                   Net cash used in investing
                    activities                               (425)                  (43)                                           (619)     (275)







                   Cash flows from financing
                    activities:


      Short- term bank credit,
       net                                                      29                    984                                              986      2,756


      Short- term shareholder
       loan                                                   (40)                                                                 1,390      1,430


      Repayment of long-term
       loans from bank                                       (220)                 (233)                                           (910)     (870)


      Proceeds from long-term
       loans                                                   377                   (36)                                             378        167


      Repayment of credit from
       fixed asset payables                                   (83)                  (32)                                           (317)     (239)


                   Net cash provided by (used
                    in) financing activities                    64                    683                                            1,527      3,244





                   Effect of translation
                    adjustments                                 15                     20                                               10        128




                   Net increase (decrease) in
                    cash and cash equivalents                (210)                 (116)                                             105      (347)





                   Cash and cash equivalents at
                    beginning of the period                  1,202                  1,003                                              887      1,234





                   Cash and cash equivalents at
                    period end                                 992                    887                                              992        887

Investor Contact:

Alon Mualem
Chief Financial Officer
alonm@nisteceltek.com
+972-3-9395023

View original content:http://www.prnewswire.com/news-releases/eltek-reports-fourth-quarter-and-full-year-2018-financial-results-300833720.html

SOURCE Eltek Ltd.